April is going to work out to be a big month for Advaxis.
3 poster abstracts at AACR on 20 th and 21st April.
Should hear more on Aduro IPO.
Many other PR's could also come, still lots to take off the 1st half of 2015 anticipated milestones.
From this comment in PR they are trying to highlight difference between Aduro and Advaxis.
Importantly, we are not aware of any other Lm technology that has demonstrated or has the ability to dose safely and effectively at 1 x 1010 CFU
Did the PR regarding Abstracts not come out after close yesterday or was it during market hrs. I am in UK at moment so my timings are a bit off at the moment.
Was anyone else suprised to see a PR last night after close. Very unusual for Advaxis to issue a PR at this time, they normally wait until the morning.
Why did they not wait to issue PR before market opens, could it be they have another PR to issue this morning.
I believe is a tox issue
Big difference between Advaxis and Aduro vaccine - Aduro vaccine has issues with multiple dosing, Advaxis does not.
As of 31st Jan Advaxis had over 30.5 million in the bank. Add the 23 we got in Feb, I would say things look in great shape.
Estimating with everything they have going on, okay until 2017.
Wonder what time shorts start covering. Got to think they will not want to hold over weekend with pending data being presented.
How many shorts will cover on Friday.
If i was short, i don't think that I would want to hold over the weekend, knowing that Brown University are going to provide an Oral presentation of Data.
Shorts is it worth the risk?
Have to agree, I think it's coming.
Also news today clearly impacts phase 3 trial, no doubt that is going to include multiple dosing.
You really have to compare the figures against historical;
"Recurrent or persistent metastatic carcinoma of the cervix has a 12-month survival rate of 10-15%"
Trial has been updated, i looked yesterday and it showed study was not yet open.
IT HAS NOW BEEN CHANGED TO;
This study is ongoing, but not recruiting participants